Catalyst Pharmaceuticals Inc
NASDAQ:CPRX

Watchlist Manager
Catalyst Pharmaceuticals Inc Logo
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX
Watchlist
Price: 24.45 USD 0.91%
Market Cap: 3B USD

Wall Street
Price Targets

CPRX Price Targets Summary
Catalyst Pharmaceuticals Inc

Wall Street analysts forecast CPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CPRX is 35.19 USD with a low forecast of 32.32 USD and a high forecast of 42 USD.

Lowest
Price Target
32.32 USD
32% Upside
Average
Price Target
35.19 USD
44% Upside
Highest
Price Target
42 USD
72% Upside
Catalyst Pharmaceuticals Inc Competitors:
Price Targets
300601
Shenzhen Kangtai Biological Products Co Ltd
31% Upside
TGTX
TG Therapeutics Inc
45% Upside
ALT
Altimmune Inc
373% Upside
688266
Suzhou Zelgen Biopharmaceuticals Co Ltd
48% Upside
AMRN
Amarin Corporation PLC
11% Downside
TVTX
Travere Therapeutics Inc
5% Upside
ASMB
Assembly Biosciences Inc
43% Upside
4587
PeptiDream Inc
96% Upside

Revenue
Forecast

Revenue Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 4 years is 11%.

N/A
Past Growth
11%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 4 years is 14%.

N/A
Past Growth
14%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Catalyst Pharmaceuticals Inc

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 4 years is 29%.

N/A
Past Growth
29%
Estimated Growth
Estimates Accuracy
-28%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CPRX's stock price target?
Price Target
35.19 USD

According to Wall Street analysts, the average 1-year price target for CPRX is 35.19 USD with a low forecast of 32.32 USD and a high forecast of 42 USD.

What is Catalyst Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
11%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's revenue for the next 4 years is 11%.

What is Catalyst Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
14%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's operating income for the next 4 years is 14%.

What is Catalyst Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
29%

The compound annual growth rate of Catalyst Pharmaceuticals Inc's net income for the next 4 years is 29%.

Back to Top